Challenges in respiratory vaccine development include immune response elicitation, personalized data, and alternative delivery methods like oral or intranasal routes to improve compliance. Federal ...

Nanovaccines show promise in breast cancer therapy, enhancing immune activation and targeting cold tumors, particularly in ...

Scientists have found a way to transform hard-to-treat tumors into targets for the immune system. Using two protein stimulators, they activated strong T-cell and B-cell responses and built immune ...

GEO-CM04S1 Designed to Deliver Broader, More Durable Protection for the 40 Million Americans Left Vulnerable by Limited ...

The researchers argue that traditional vaccine development methods, which rely heavily on laboratory experimentation and long ...

This review uncovers how aging reshapes immunoglobulins, particularly IgG, IgM, and IgA, driving inflammation, cellular ...

Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today presented positive topline data from Part 1 of ...

Infectious bursal disease (IBD) is an immunosuppressive poultry disease. Reported globally, it can infect young broilers from ...

Early broadly neutralising antibody responses against the E1E2 glycoprotein seem to be important for preventing persistence ...